📊 Score Breakdown
Offering Ability
60
Cash Runway
0
Float Risk
72
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
42%
🔁 Convertible Conversion
60%
• Major convertible overhang: 43% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split
30%
• 50-day avg $1.06 approaching $1 threshold
💰 Capital Raise
18%
• Active ATM program with $75M remaining capacity
💹 Market Data
Market Cap$27.57M
Shares Outstanding40.84M
Float15.80M
Cash$679.4K
Debt$4.67M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 18.9% shares (2025Q4 vs prior)
16 institutional holders · 700.7K shares
#1
VAN ECK ASSOCIATES CORP
415.8K shares
#2
MARSHALL WACE, LLP
83.0K shares
#3
Qube Research & Technologies Ltd
36.8K shares
+ 13 more holders Sign up free to view →
📉 Short Interest
Short Interest174.1K
Days to Cover1.0
% of Float1.1%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2025
6-K
8K EVENT
Apr 07, 2026
4
INSIDER TRANSACTION
Apr 06, 2026
6-K
8K EVENT
Mar 31, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for BGL
📊 BGL FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 BGL Signal Convergence & Dark Pool Activity — StonkWhisper
📄 BGL Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.